Monday, September 27, 2021 12:49:02 PM
Does someone have a different scenario?
BTW I own SENS and they are expecting FDA approval for their sensor this month and no news yet. That is why I base my January scenario on CTXR.
Recent CTXR News
- Form 8-K - Current report • Edgar (US Regulatory) • 02/13/2026 01:30:27 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/13/2026 01:00:57 PM
- Citius Oncology, Inc. Announces First Reported Revenue Following Successful Launch of LYMPHIR™ • PR Newswire (US) • 02/13/2026 01:00:00 PM
- Citius Pharmaceuticals, Inc. Announces First Reported Revenue Following Successful Launch of LYMPHIR™ • PR Newswire (US) • 02/13/2026 01:00:00 PM
- Citius Oncology Expands International Distribution of LYMPHIR™ to European Union Through Exclusive Agreement with Uniphar • PR Newswire (US) • 02/11/2026 01:00:00 PM
- Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend] • Edgar (US Regulatory) • 01/28/2026 09:30:18 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/23/2025 09:49:06 PM
- Citius Pharmaceuticals, Inc. Reports Fiscal Year 2025 Financial Results and Provides Business Update • PR Newswire (US) • 12/23/2025 09:30:00 PM
- Citius Oncology, Inc. Reports Fiscal Year 2025 Financial Results and Provides Business Update • PR Newswire (US) • 12/23/2025 09:30:00 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 12/23/2025 09:21:08 PM
- Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend] • Edgar (US Regulatory) • 12/17/2025 09:10:08 PM
- Citius Oncology Shares Sink After Announcing $18M Fundraising Deal • IH Market News • 12/09/2025 03:19:37 PM
- Citius Oncology Announces $18 Million Concurrent Registered Direct Offering and Private Placement Priced At-The-Market Under Nasdaq Rules • PR Newswire (US) • 12/09/2025 01:30:00 PM
- Citius Oncology Expands LYMPHIR™ Distribution to Turkey and Middle East Countries Through Exclusive Agreement with Er-Kim • PR Newswire (US) • 12/04/2025 01:37:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/01/2025 10:03:08 PM
- Citius Oncology Announces U.S. Commercial Launch of LYMPHIR™, a Novel Cancer Immunotherapy for Cutaneous T-Cell Lymphoma (CTCL) • PR Newswire (US) • 12/01/2025 05:00:00 PM
- Citius Oncology to Advance Commercial Launch of LYMPHIR™ with Verix AI Integration • PR Newswire (US) • 11/21/2025 01:37:00 PM
- Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 10/27/2025 02:47:18 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/23/2025 09:12:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/21/2025 08:41:25 PM
- Citius Pharmaceuticals Announces the Closing of Registered Direct Offering of $6.0 Million Priced At-The-Market Under Nasdaq Rules • PR Newswire (US) • 10/21/2025 08:30:00 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 10/21/2025 01:24:12 PM
- Citius Pharmaceuticals Announces a Registered Direct Offering of $6.0 Million Priced At-The-Market Under Nasdaq Rules • PR Newswire (US) • 10/21/2025 12:00:00 PM
- Citius Oncology Signs U.S. Distribution Agreement with McKesson to Support LYMPHIR™ Commercial Launch • PR Newswire (US) • 10/20/2025 12:37:00 PM
- Citius Pharmaceuticals and Citius Oncology to Participate in Upcoming October 2025 Conferences • PR Newswire (US) • 10/17/2025 09:00:00 PM
UPDATE: Hydromer, Inc. Announces Expansion Into High-Speed Automated Coating and UV Cure Equipment Manufacturing • HYDI • Feb 10, 2026 10:58 AM
MedWell Ai Executes Letter Of Intent To Create America's First Vertically Integrated Regenerative Wellness Eco-System • MWAI • Feb 10, 2026 8:45 AM
LaFleur Minerals Reports Assay Results Highlighting 2.05 g/t Au over 158.25 metres, Confirming Strong Gold Continuity at Swanson Gold Project • LFLRF • Feb 5, 2026 5:29 AM
DRCR Begins Rollout of New Business Model • DRCR • Feb 4, 2026 12:42 PM
BIO-PATH HOLDINGS ANNOUNCES "BPTH 2.0" STRATEGIC PIVOT ON WORLD CANCER DAY; ENGAGES LEGAL COUNSEL FOR REGULATION A OFFERING • BPTH • Feb 4, 2026 10:00 AM
Branded Legacy, Inc. (OTC: BLEG) Successfully Negotiates Retirement of Four Additional Convertible Notes, Preventing Potential Dilution of Hundreds of Millions of Shares • BLEG • Feb 4, 2026 9:07 AM
